Purchasing the Daisy Crowd Fund packages is a contribution to the equity crowd fund for the Daisy AI development and not a trading investment. Endotech is giving both shares of stock in the company and profit sharing from trading results, to each contributor as crowd funding rewards.
Prior to Endotech going public, shares of Endotech stock will be rewarded to each Crowd Fund contributor. Stock certificates will require a KYC verification of each member’s legal identity before any shares of stock can be rewarded. In the case that Endotech does not go public, the equity will be converted into dividends for each member.
The trading accounts will be used for the purpose of testing and developing. Past performance does not guarantee future results, and is for informational purposes only. Historical performances shown are also the result of compounding profits. Profit rewards are contingent upon profitable trading performance and results are not a guarantee. All performance will be visible with full transparency to each crowd fund member.
Up to 46% of funds are designated in the Smart Contract for marketing via the referral rewards plan.
Daisy is not available in the US, North Korea or Iran.
